TMEM115
gene geneOn this page
Also known as PL6
Summary
TMEM115 (transmembrane protein 115, HGNC:30055) is a protein-coding gene on chromosome 3p21.31, encoding Transmembrane protein 115 (Q12893). May play a role in retrograde transport of proteins from the Golgi to the endoplasmic reticulum.
Enables identical protein binding activity. Involved in retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum. Located in Golgi cisterna membrane; Golgi transport complex; and nucleus.
Source: NCBI Gene 11070 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- MANE Select transcript:
NM_007024
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30055 |
| Approved symbol | TMEM115 |
| Name | transmembrane protein 115 |
| Location | 3p21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PL6 |
| Ensembl gene | ENSG00000126062 |
| Ensembl biotype | protein_coding |
| OMIM | 607069 |
| Entrez | 11070 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000266025, ENST00000901094, ENST00000972195
RefSeq mRNA: 1 — MANE Select: NM_007024
NM_007024
CCDS: CCDS2828
Canonical transcript exons
ENST00000266025 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000860752 | 50358213 | 50359521 |
| ENSE00001081145 | 50354750 | 50355547 |
Expression profiles
Bgee: expression breadth ubiquitous, 281 present calls, max score 91.79.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.0013 / max 103.8190, expressed in 1813 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 42337 | 19.2575 | 1813 |
| 42338 | 0.7439 | 482 |
Top tissues by expression
298 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| stromal cell of endometrium | CL:0002255 | 91.79 | gold quality |
| apex of heart | UBERON:0002098 | 91.71 | gold quality |
| skin of leg | UBERON:0001511 | 91.54 | gold quality |
| left adrenal gland | UBERON:0001234 | 90.91 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 90.88 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 90.86 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 90.83 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 90.80 | gold quality |
| skin of abdomen | UBERON:0001416 | 90.78 | gold quality |
| lower esophagus | UBERON:0013473 | 90.78 | gold quality |
| right adrenal gland | UBERON:0001233 | 90.77 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 90.77 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 90.72 | gold quality |
| body of stomach | UBERON:0001161 | 90.64 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 90.62 | gold quality |
| left coronary artery | UBERON:0001626 | 90.36 | gold quality |
| right coronary artery | UBERON:0001625 | 90.22 | gold quality |
| left uterine tube | UBERON:0001303 | 90.07 | gold quality |
| mucosa of stomach | UBERON:0001199 | 90.01 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 89.96 | gold quality |
| coronary artery | UBERON:0001621 | 89.81 | gold quality |
| adrenal cortex | UBERON:0001235 | 89.79 | gold quality |
| transverse colon | UBERON:0001157 | 89.77 | gold quality |
| thoracic aorta | UBERON:0001515 | 89.77 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 89.73 | gold quality |
| thyroid gland | UBERON:0002046 | 89.72 | gold quality |
| ascending aorta | UBERON:0001496 | 89.66 | gold quality |
| aorta | UBERON:0000947 | 89.50 | gold quality |
| right atrium auricular region | UBERON:0006631 | 89.46 | gold quality |
| popliteal artery | UBERON:0002250 | 89.44 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.70 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): VHL
miRNA regulators (miRDB)
33 targeting TMEM115, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7152-3P | 99.97 | 67.47 | 849 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-142-3P | 99.62 | 71.30 | 974 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-451B | 99.55 | 68.28 | 1380 |
| HSA-MIR-486-5P | 99.51 | 70.39 | 707 |
| HSA-MIR-140-5P | 99.44 | 67.20 | 792 |
| HSA-MIR-4460 | 99.37 | 68.52 | 615 |
| HSA-MIR-361-3P | 99.19 | 66.45 | 1381 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-328-5P | 99.08 | 64.65 | 1000 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-7851-3P | 98.72 | 64.88 | 980 |
| HSA-MIR-6501-3P | 98.71 | 67.45 | 1480 |
| HSA-MIR-4700-5P | 98.63 | 67.43 | 1915 |
| HSA-MIR-4274 | 98.59 | 66.10 | 630 |
| HSA-MIR-6742-3P | 97.95 | 64.50 | 1490 |
| HSA-MIR-203B-5P | 97.24 | 68.54 | 543 |
| HSA-MIR-6718-5P | 97.24 | 68.15 | 553 |
| HSA-MIR-410-5P | 96.55 | 66.28 | 459 |
| HSA-MIR-323B-5P | 96.12 | 66.39 | 472 |
| HSA-MIR-6726-5P | 95.97 | 63.72 | 841 |
| HSA-MIR-920 | 95.97 | 63.95 | 811 |
| HSA-MIR-4300 | 95.85 | 64.56 | 1003 |
| HSA-MIR-5591-5P | 95.85 | 64.76 | 1002 |
Literature-anchored findings (GeneRIF, showing 1)
- Results establish that TMEM115 is an integral membrane protein of the Golgi stack regulating Golgi-to-ER retrograde transport and is likely to be part of the machinery of the COG complex. (PMID:24806965)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem115 | ENSDARG00000055763 |
| mus_musculus | Tmem115 | ENSMUSG00000010045 |
| rattus_norvegicus | Tmem115 | ENSRNOG00000021899 |
| drosophila_melanogaster | CG9536 | FBGN0031818 |
| caenorhabditis_elegans | WBGENE00008687 |
Protein
Protein identifiers
Transmembrane protein 115 — Q12893 (reviewed: Q12893)
Alternative names: Placental protein 6, Protein PL6
All UniProt accessions (2): Q12893, A0A024R2Y2
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in retrograde transport of proteins from the Golgi to the endoplasmic reticulum. May indirectly play a role in protein glycosylation in the Golgi.
Subunit / interactions. Homooligomer. Interacts with COPB1. May interact with LMAN1. Interacts with the COG complex; probably through COG3.
Subcellular location. Golgi apparatus. Golgi stack membrane.
Tissue specificity. Expressed strongly in kidney and skeletal muscle, followed by liver, placenta, pancreas, and lung, with low amounts in heart and only traces in brain. Widely expressed with ubiquitous expression in epithelial tissues (at protein level).
Similarity. Belongs to the TMEM115 family.
RefSeq proteins (1): NP_008955* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013861 | TMEM115/Pdh1/Rbl19 | Family |
| IPR035952 | Rhomboid-like_sf | Homologous_superfamily |
Pfam: PF08551
UniProt features (14 total): topological domain 5, transmembrane region 4, region of interest 3, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q12893-F1 | 79.11 | 0.47 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 329
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6807878 | COPI-mediated anterograde transport |
MSigDB gene sets: 122 (showing top):
RRAGTTGT_UNKNOWN, GCAAGGA_MIR502, GOBP_VESICLE_MEDIATED_TRANSPORT, REACTOME_MEMBRANE_TRAFFICKING, GGAMTNNNNNTCCY_UNKNOWN, HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3, AACWWCAANK_UNKNOWN, IRF7_01, WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP, GRE_C, WANG_CISPLATIN_RESPONSE_AND_XPC_DN, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, CAAGGAT_MIR362, ACTWSNACTNY_UNKNOWN, GOCC_GOLGI_STACK
GO Biological Process (3): retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890), negative regulation of cell population proliferation (GO:0008285), protein transport (GO:0015031)
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (6): Golgi membrane (GO:0000139), nucleus (GO:0005634), Golgi apparatus (GO:0005794), Golgi cisterna membrane (GO:0032580), membrane (GO:0016020), COG complex (GO:0017119)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| ER to Golgi Anterograde Transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| Golgi apparatus | 2 |
| intracellular membrane-bounded organelle | 2 |
| Golgi vesicle transport | 1 |
| cell population proliferation | 1 |
| regulation of cell population proliferation | 1 |
| negative regulation of cellular process | 1 |
| transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| protein binding | 1 |
| binding | 1 |
| bounding membrane of organelle | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| organelle membrane | 1 |
| Golgi cisterna | 1 |
| cellular anatomical structure | 1 |
| vesicle tethering complex | 1 |
Protein interactions and networks
STRING
718 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM115 | UBAC2 | Q8NBM4 | 494 |
| TMEM115 | TMEM101 | Q96IK0 | 472 |
| TMEM115 | TMEM208 | Q9BTX3 | 468 |
| TMEM115 | TMEM59L | Q9UK28 | 445 |
| TMEM115 | RHBDD2 | Q6NTF9 | 411 |
| TMEM115 | A0A1W2PP11 | A0A1W2PP11 | 393 |
| TMEM115 | CDKN2A | P42771 | 392 |
| TMEM115 | PARL | Q9H300 | 391 |
| TMEM115 | CYB561D2 | O14569 | 384 |
| TMEM115 | RHBDD3 | Q9Y3P4 | 371 |
| TMEM115 | RHBDF1 | Q96CC6 | 370 |
| TMEM115 | ZMYND10 | O75800 | 369 |
| TMEM115 | STX16 | O14662 | 369 |
| TMEM115 | RHBDL1 | O75783 | 367 |
| TMEM115 | RHBDF2 | Q6PJF5 | 351 |
IntAct
69 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM115 | SYNE4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SYNE4 | TMEM115 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | AQP6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | ASPG | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | TMED8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYB5R3 | TMEM115 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | RABAC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | HTATIP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | MANBAL | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | TLCD4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| TMEM115 | LAMP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM115 | SH3GLB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HTT | TMEM115 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SCN3B | ABCC5 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC22A9 | GPR89A | psi-mi:“MI:0914”(association) | 0.530 |
| SLC22A16 | APBA3 | psi-mi:“MI:0914”(association) | 0.530 |
| NRAS | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.480 |
BioGRID (74): SYNE4 (Two-hybrid), TMEM115 (Two-hybrid), TMEM115 (Proximity Label-MS), TMEM115 (Proximity Label-MS), TMEM115 (Two-hybrid), TMEM115 (Affinity Capture-MS), TMEM115 (Affinity Capture-MS), TMEM115 (Affinity Capture-MS), TMEM115 (Proximity Label-MS), TMEM115 (Proximity Label-MS), TMEM115 (Affinity Capture-MS), TMEM115 (Proximity Label-MS), TMEM115 (Two-hybrid), TMEM115 (Two-hybrid), TMEM115 (Two-hybrid)
ESM2 similar proteins: A4FUB8, E9QBI7, O35394, O95070, O97681, P15920, P58872, P58873, Q0DWA9, Q0P5E4, Q12270, Q12893, Q13488, Q1RMH4, Q28C60, Q3UVK0, Q4V8F3, Q52NJ0, Q5RBS4, Q5XIT3, Q5Z413, Q6BSA9, Q6C741, Q6CDV6, Q6CR06, Q6DCK1, Q6FSG0, Q6P6G5, Q6UPR8, Q755H8, Q7Z2K6, Q874X5, Q8BHC7, Q8BXJ9, Q8RXQ2, Q8TEB9, Q8VC82, Q8VZ96, Q91VU1, Q91XB7
Diamond homologs: A4FUB8, Q12893, Q8LF05, Q9WUH1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
482 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:50355545:TGC:T | acceptor_gain | 1.0000 |
| 3:50355545:TGCC:T | acceptor_loss | 1.0000 |
| 3:50355546:GCC:G | acceptor_loss | 1.0000 |
| 3:50355547:CCTGG:C | acceptor_loss | 1.0000 |
| 3:50355548:C:CA | acceptor_loss | 1.0000 |
| 3:50355548:C:CC | acceptor_gain | 1.0000 |
| 3:50355549:T:G | acceptor_loss | 1.0000 |
| 3:50355555:C:CT | acceptor_gain | 1.0000 |
| 3:50355555:C:T | acceptor_gain | 1.0000 |
| 3:50355556:A:T | acceptor_gain | 1.0000 |
| 3:50358208:AGTAC:A | donor_loss | 1.0000 |
| 3:50358209:GTACC:G | donor_loss | 1.0000 |
| 3:50358210:TAC:T | donor_loss | 1.0000 |
| 3:50358211:A:AG | donor_loss | 1.0000 |
| 3:50358212:C:A | donor_loss | 1.0000 |
| 3:50358212:CCTT:C | donor_gain | 1.0000 |
| 3:50355543:GTTGC:G | acceptor_gain | 0.9900 |
| 3:50355544:TTGC:T | acceptor_gain | 0.9900 |
| 3:50355546:GC:G | acceptor_gain | 0.9900 |
| 3:50355547:CC:C | acceptor_gain | 0.9900 |
| 3:50357266:A:T | acceptor_gain | 0.9900 |
| 3:50357391:C:CT | donor_gain | 0.9900 |
| 3:50357392:T:TT | donor_gain | 0.9900 |
| 3:50358461:A:C | donor_gain | 0.9900 |
| 3:50355548:C:T | acceptor_gain | 0.9800 |
| 3:50356602:C:A | donor_gain | 0.9800 |
| 3:50358211:A:AC | donor_gain | 0.9800 |
| 3:50358212:C:CC | donor_gain | 0.9800 |
| 3:50357265:CAG:C | acceptor_gain | 0.9700 |
| 3:50358376:C:CT | acceptor_gain | 0.9700 |
AlphaMissense
2238 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:50355527:A:G | L291P | 0.999 |
| 3:50355527:A:T | L291H | 0.999 |
| 3:50355536:A:G | L288P | 0.999 |
| 3:50358255:A:G | I270T | 0.999 |
| 3:50355515:A:G | L295P | 0.998 |
| 3:50355539:G:T | A287D | 0.998 |
| 3:50355547:C:A | R284S | 0.998 |
| 3:50355547:C:G | R284S | 0.998 |
| 3:50358219:C:G | R282P | 0.998 |
| 3:50358255:A:T | I270N | 0.998 |
| 3:50358443:G:C | F207L | 0.998 |
| 3:50358443:G:T | F207L | 0.998 |
| 3:50358445:A:G | F207L | 0.998 |
| 3:50355542:A:G | L286P | 0.997 |
| 3:50358213:C:A | R284M | 0.997 |
| 3:50358213:C:G | R284T | 0.997 |
| 3:50358255:A:C | I270S | 0.997 |
| 3:50358461:A:C | S201R | 0.997 |
| 3:50358461:A:T | S201R | 0.997 |
| 3:50358463:T:G | S201R | 0.997 |
| 3:50355531:C:G | A290P | 0.996 |
| 3:50355540:C:T | A287T | 0.996 |
| 3:50358215:T:A | R283S | 0.996 |
| 3:50358215:T:G | R283S | 0.996 |
| 3:50358261:A:G | I268T | 0.996 |
| 3:50358886:A:G | W60R | 0.996 |
| 3:50358886:A:T | W60R | 0.996 |
| 3:50355518:C:G | R294P | 0.995 |
| 3:50358216:C:G | R283T | 0.995 |
| 3:50358460:A:G | W202R | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000111239 (3:50359764 G>A), RS1000619900 (3:50360067 A>G), RS1001118108 (3:50361342 T>G), RS1002140246 (3:50360439 T>G), RS1002576811 (3:50355036 A>G), RS1002586670 (3:50355156 T>C), RS1003583860 (3:50356765 G>A), RS1003681720 (3:50356203 G>A,T), RS1004023337 (3:50355922 T>C), RS1004029001 (3:50356457 G>T), RS1004076448 (3:50356020 G>A), RS1004345617 (3:50359470 G>A), RS1004537271 (3:50355670 T>C), RS1004743833 (3:50359108 G>A,C), RS1005334242 (3:50360643 G>A)
Disease associations
OMIM: gene MIM:607069 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007559_24 | Sleep duration (short sleep) | 3.000000e-08 |
| GCST010698_80 | Subcortical volume (min-P) | 3.000000e-24 |
| GCST010699_110 | Brain morphology (min-P) | 4.000000e-08 |
| GCST010701_52 | Cortical surface area (MOSTest) | 1.000000e-16 |
| GCST010702_36 | Subcortical volume (MOSTest) | 1.000000e-10 |
| GCST010703_262 | Brain morphology (MOSTest) | 2.000000e-13 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | increases abundance, increases expression, affects methylation, affects cotreatment | 2 |
| Cyclosporine | decreases methylation, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | increases phosphorylation | 1 |
| bisphenol F | increases expression, affects cotreatment | 1 |
| triphenyl phosphate | affects expression | 1 |
| pirinixic acid | affects binding, decreases expression, increases activity | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| cobaltous chloride | increases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| MT19c compound | decreases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Quercetin | increases phosphorylation | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Sodium Selenite | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_C8A6 | HEK293 TMEM115-3xHA GolgiTAG | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.